Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Herpes simplex virus oncolytic vaccine therapy in melanoma
Shanthi Sivendran, Michael Pan, Howard L. Kaufman, et al.
Expert Opinion on Biological Therapy (2010) Vol. 10, Iss. 7, pp. 1145-1153
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair, Heather J. Bax, Silvia Mele, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 220
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe, Karen L. Mossman
Molecular Therapy (2013) Vol. 22, Iss. 2, pp. 251-256
Open Access | Times Cited: 178
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
Valerio Leoni, Andrea Vannini, Valentina Gatta, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 8, pp. e1007209-e1007209
Open Access | Times Cited: 67
Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy
Yu-Ping Liu, Lukkana Suksanpaisan, Michael B. Steele, et al.
Scientific Reports (2013) Vol. 3, Iss. 1
Open Access | Times Cited: 62
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition
Victoria A. Jennings, Gina B. Scott, Ailsa M.S. Rose, et al.
Molecular Therapy (2019) Vol. 27, Iss. 6, pp. 1139-1152
Open Access | Times Cited: 50
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Arthur Dyer, Ying Di, Hugo Calderón, et al.
Molecular Therapy — Oncolytics (2016) Vol. 4, pp. 18-30
Open Access | Times Cited: 48
Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
Maxine Bauzon, Terry Hermiston
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 42
Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer
Sepideh Gholami, C-H Chen, Sizhi Paul Gao, et al.
Cancer Gene Therapy (2014) Vol. 21, Iss. 7, pp. 283-289
Open Access | Times Cited: 41
Triple-negative breast cancer: new perspectives for novel therapies
Yashin A. Mahamodhossen, Wei Liu, Rongrong Zhou
Medical Oncology (2013) Vol. 30, Iss. 3
Open Access | Times Cited: 34
Biological delivery approaches for gene therapy: Strategies to potentiate efficacy and enhance specificity
Elham Mohit, Sima Rafati
Molecular Immunology (2013) Vol. 56, Iss. 4, pp. 599-611
Closed Access | Times Cited: 31
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
Xin Xie, Jingwen Lv, Wei Zhu, et al.
Translational Oncology (2021) Vol. 15, Iss. 1, pp. 101287-101287
Open Access | Times Cited: 20
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 2
Oncolytic Viruses: Smart Therapeutics for Smart Cancers
Rebecca C. Auer, John C. Bell
Future Oncology (2011) Vol. 8, Iss. 1, pp. 1-4
Closed Access | Times Cited: 21
Viral Oncolysis — Can Insights from Measles Be Transferred to Canine Distemper Virus?
Stefanie Lapp, Vanessa M. Pfankuche, Wolfgang Baumgärtner, et al.
Viruses (2014) Vol. 6, Iss. 6, pp. 2340-2375
Open Access | Times Cited: 15
Results of a Randomized Phase I Gene Therapy Clinical Trial of Nononcolytic Fowlpox Viruses Encoding T Cell Costimulatory Molecules
Howard L. Kaufman, Daewon Kim, Seunghee Kim‐Schulze, et al.
Human Gene Therapy (2014) Vol. 25, Iss. 5, pp. 452-460
Open Access | Times Cited: 14
Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology
Mark B. Faries
Critical Reviews™ in Oncogenesis (2016) Vol. 21, Iss. 1-2, pp. 65-73
Open Access | Times Cited: 14
Melanoma Immunotherapy
Shanthi Sivendran, Bradley Glodny, Michael Pan, et al.
Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine (2010) Vol. 77, Iss. 6, pp. 620-642
Closed Access | Times Cited: 15
Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma
Alfonso Berrocal, Enrique Espinosa, Severiano Marín, et al.
European Journal of Dermatology (2015) Vol. 25, Iss. 5, pp. 392-403
Open Access | Times Cited: 12
Viral therapy for pancreatic cancer: Tackle the bad guys with poison
Can Xu, Haihang Li, Changqing Su, et al.
Cancer Letters (2013) Vol. 333, Iss. 1, pp. 1-8
Closed Access | Times Cited: 12
Talimogene laherparepvec in the treatment of melanoma
Elizabeth Appleton, Samantha Turnbull, Christy Ralph, et al.
Expert Opinion on Biological Therapy (2015) Vol. 15, Iss. 10, pp. 1517-1530
Closed Access | Times Cited: 8
Advances in Therapeutic Approaches Using RNA Interference as a Gene Silencing Tool
Burçin Tezcanlı Kaymaz, Buket Kosov
Advanced Techniques in Biology & Medicine (2013) Vol. 1, Iss. 2
Open Access | Times Cited: 7
Current and planned multicenter trials for patients with primary or metastatic melanoma
Vernon K. Sondak, Dale Han, Jeremiah L. Deneve, et al.
Journal of Surgical Oncology (2011) Vol. 104, Iss. 4, pp. 430-437
Closed Access | Times Cited: 6
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma
Robyn D. Gartrell, Zoë Blake, Emanuelle M. Rizk, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 8, pp. 1837-1849
Open Access | Times Cited: 4
Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
Ravi N. Samy, Brian R. Earl, Noga Lipschitz, et al.
Laryngoscope Investigative Otolaryngology (2019) Vol. 4, Iss. 5, pp. 532-542
Open Access | Times Cited: 3
The Virus That Came In from the Cold
John C. Bell
Science Translational Medicine (2012) Vol. 4, Iss. 138
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top